Regulatory Approval & Timelines Risk: The company's future depends on obtaining and maintaining necessary regulatory approvals (e.g., FDA clearance) for its diagnostic devices, which can be a lengthy, expensive, and uncertain process.

Commercialization & Market Adoption Risk: Even with regulatory approval, there is no guarantee of successful market penetration, physician adoption, or sufficient sales volume to achieve profitability due to various factors including pricing, reimbursement, and market acceptance.

Financial Stability & Future Funding Risk: Spectral AI is pre-revenue and operating at a significant loss, requiring substantial additional capital to fund its research, development, and commercialization efforts, which may not be available on favorable terms or at all, raising going concern risks.